Our immunohistochemistry data further showed that high ANKRD49 expression was more easily visualized in tumours at advanced TNM stages (III‐IV), lymph node metastasis, and poor distal metastasis and differentiation than in tumours at early TNM stages (I‐II), lymph node‐lacking metastasis, or moderate distal metastasis and differentiation stages. This evidence concerns the gene ANKRD49 and neoplasm.